The company has recently announced a $300,000 order of its proprietary extract and revealed four years of research and development targeting $170 billion worth of pharmaceutical treatments.
DALLAS, April 22, 2019 (GLOBE NEWSWIRE) — Kali-Extracts, Inc. (Kali, Inc. dba/Kali-Extracts, Inc.) (USOTC: KALY) (“KALY”) announced today that its Hemp4mula CBD gum is now available for sale on line at USMJ.com. KALY acquired a patented cannabis extraction process in the fourth quarter of 2019 and has rapidly implemented a multitiered strategy to monetize the value of the patented process.
The company has recently announced a $300,000 order of its proprietary extract and revealed four years of research and development targeting $170 billion worth of pharmaceutical treatments.
The announcement today is a further indication of KALY’s progress toward a $1 million revenue target for 2018 in addition to potentially building billions in asset value from its ongoing cannabis extract pharmaceutical research and development.
https://usmj.com/product/hemp4mula-gum-tablets-8pk/
A photo accompanying this announcement is available at http://www.globenewswire.com/NewsRoom/AttachmentNg/49d2fff3-1e2e-444a-a6f9-6be0086e8fa4
